There are around 55,100 new prostate cancer cases in the UK every year HBC Immunology (HBCI) has announced that an oral formulation of its lead peptide “significantly augmented” the anti-tumour ...

NK:IO has appointed Richard Hopkins as Chief Executive Officer NK:IO has appointed Richard Hopkins, an experienced biologics developer, as its new Chief Executive Officer. Hopkins has more than 14 ...

Teclistamab (Tecvayli), a drug manufactured by Johnson & Johnson, has received a positive recommendation from NICE for fourth-line use on the NHS in England and Wales. This new treatment is for ...

Cardiologists at Sheffield Teaching Hospitals NHS Foundation Trust have performed a cutting-edge heart valve replacement ...

Cancer Grand Challenges, a pioneering initiative co-founded by Cancer Research UK and the US National Cancer Institute (NCI), has launched a global search to identify the most pressing challenges in ...

IRLAB Therapeutics AB has announced the successful completion of the first part of its Phase I clinical trial for IRL757, a drug candidate aimed at treating apathy in patients with Parkinson’s disease ...

The Scottish Medicines Consortium (SMC) has recommended MSD’s KEYTRUDA (pembrolizumab) as a monotherapy for adults with non-small cell lung carcinoma (NSCLC) who are at high risk of recurrence ...

In a landmark study, Johnson & Johnson has announced that ERLEADA (apalutamide) significantly reduces the risk of death by 23% at 24 months compared to enzalutamide in patients with metastatic ...

Insilico Medicine, a clinical-stage generative AI-driven drug discovery company, has announced positive preliminary results from its Phase 2a clinical trial of ISM001-055. This first-in-class small ...

Oxford Drug Design has been awarded a share of a £3 million Collaborative Discovery Programme (CDP) by the Cystic Fibrosis Antimicrobial Resistance (CF AMR) Syndicate. This initiative, funded by the ...

International trial marks leap forward in chemotherapy-induced neuropathy care In a landmark announcement from Paris, AlgoTherapeutix (AlgoTx) has heralded the successful completion of its ...

Biotech company moves forward with phase 2 trial for precision cancer surgery Copenhagen-based biotech company FluoGuide A/S has announced the submission of a Clinical Trial Application (CTA) for a ...